The FDA updated its READI-Home Innovation Challenge page, which focuses on reducing readmissions through device innovation for home use. Although it is less directly legal than fraud or enforcement news, the initiative is relevant to healthcare governance because it shows the agency encouraging device development in an area tied to home-based care and hospital readmission policy. The page also reflects FDA interest in how oversight and innovation intersect in the home-health device space.
